A simpler colon cancer screening pathway
Part of Cancer, Digestive system clinical trials.
This study tests if a more straightforward screening process can work better for people referred with possible colon cancer symptoms. It looks at how a positive stool test (FIT) leads to a diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were referred to the NHS Lothian urgent colon cancer pathway with symptoms like bleeding or a change in bowel habits.
- You had a positive FIT (stool test) result as part of that referral.
- You are a new patient referred during the study period and not already under follow-up for polyps or previous cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a stool microbiome test can help find colorectal cancer early in people who already had a positive FIT screening test. You would give a stool sample and your microbiome results will be compared to what the colonoscopy finds.
This trial compares different ways to screen healthy adults aged 45–74 for colorectal cancer using non-invasive tests. If you join, you will help find the best method to catch cancer early and prevent it.
This trial tests a program to help people who had an abnormal FIT stool test follow through with getting a colonoscopy. The goal is to improve cancer screening by providing extra support through a care team and technology.
This trial tests a new tool that looks at gut bacteria to help find colorectal cancer earlier. It's for people who already had a positive result on a standard stool test (FIT) as part of a national screening program.
This trial is testing a new way to screen for colorectal cancer in adults aged 45 to 74. If you join, you will help researchers find better methods for early detection.
This trial checks a stool test called FIT-DNA after colorectal (colon) cancer surgery. It aims to see whether this test can help doctors monitor for recurrence during follow-up and decide how closely to watch.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.